en
svPress releases
Regulatory press release 2026-05-12
Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026
Regulatory press release 2026-04-30
New number of shares and votes in Xspray Pharma after new share issue April 2026
Regulatory press release 2026-04-28
Interim Report First Quarter 2026
Regulatory press release 2026-04-23
Xspray’s rights issue oversubscribed – over-allotment issue fully utilized
Regulatory press release 2026-04-09
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2026-03-31
Xspray publishes disclosure document regarding rights issue
Regulatory press release 2026-03-26
Xspray Pharma publishes its Annual Report 2025
Regulatory press release 2026-03-24
Xspray resolves on a rights issue of approximately SEK 83 million with an over-allotment issue
Regulatory press release 2026-02-26
Xspray Pharma appoints Blake Leitch as CEO – Per Andersson continues as Chief Scientific Officer (CSO)
Regulatory press release 2026-02-12